» Articles » PMID: 7979545

Photodynamic Therapy in Psoriasis: Suppression of Cytokine Production in Vitro and Recording of Fluorescence Modification During Treatment in Vivo

Overview
Specialty Dermatology
Date 1994 Jan 1
PMID 7979545
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Photodynamic therapy (PDT) consists of the combination of photosensitizers absorbing light mainly in the red spectral region and irradiation with light of corresponding wavelengths. We analysed its effects on the cytokine secretion (IL-1 beta, TNF alpha, IL-6) of freshly isolated peripheral mononuclear cells from six patients with chronic plaque-stage psoriasis in comparison with PUVA. PUVA treatment resulted in a decreased production of all three cytokines, but most pronounced in the case of IL-6. PDT caused a similar change in the cytokine pattern, but its effectiveness was lower. In vivo fluorescence recordings were performed on psoriatic plaque lesions after topical application of the photosensitizer Photosan-3. Under irradiation, progressive photobleaching was noted with increasing radiation dosage. This is the first reported study of photochemical reactions using on-line fluorescence recordings during PDT of psoriatic lesions in vivo. Our results demonstrate the capacity of PDT to cause immunomodulatory effects similar to PUVA, thus indicating its potential application to the treatment of this common disease.

Citing Articles

Skin cancer detection using non-invasive techniques.

Narayanamurthy V, Padmapriya P, Noorasafrin A, Pooja B, Hema K, Yuhainis Firus Khan A RSC Adv. 2022; 8(49):28095-28130.

PMID: 35542700 PMC: 9084287. DOI: 10.1039/c8ra04164d.


Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.

Maytin E, Honari G, Khachemoune A, Taylor C, Ortel B, Pogue B Isr J Chem. 2012; 52(8-9):767-775.

PMID: 23264699 PMC: 3526008. DOI: 10.1002/ijch.201200005.


Structure-activity relationships of diphenyl-ether as protoporphyrinogen oxidase inhibitors: insights from computational simulations.

Hao G, Tan Y, Yu N, Yang G J Comput Aided Mol Des. 2011; 25(3):213-22.

PMID: 21259066 DOI: 10.1007/s10822-011-9412-6.


[Photodynamic therapy: non-oncologic indications].

Karrer S, Szeimies R Hautarzt. 2007; 58(7):585-96.

PMID: 17546432 DOI: 10.1007/s00105-007-1347-4.

References
1.
Parrish J, Fitzpatrick T, Tanenbaum L, Pathak M . Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974; 291(23):1207-11. DOI: 10.1056/NEJM197412052912301. View

2.
Musser D, Fiel R . Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem Photobiol. 1991; 53(1):119-23. DOI: 10.1111/j.1751-1097.1991.tb08476.x. View

3.
Kostron H, Bellnier D, Lin C, Swartz M, Martuza R . Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection. J Neurosurg. 1986; 64(5):768-74. DOI: 10.3171/jns.1986.64.5.0768. View

4.
Bos J . The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol. 1988; 118(2):141-55. DOI: 10.1111/j.1365-2133.1988.tb01768.x. View

5.
MCCAUGHAN Jr J . Photodynamic therapy of skin and esophageal cancers. Cancer Invest. 1990; 8(3-4):407-16. DOI: 10.3109/07357909009012058. View